How ITAMs inhibit signaling
- PMID: 21505184
- PMCID: PMC3261782
- DOI: 10.1126/scisignal.2001917
How ITAMs inhibit signaling
Abstract
Immunoreceptor tyrosine-based activation motifs (ITAMs) are used by multiple receptors to activate immune cells. However, ITAM-associated receptors can have paradoxically inhibitory effects, which have been implicated in regulation of inflammatory responses, but mechanisms of inhibitory signaling are poorly understood. New evidence shows that low avidity ligation of the ITAM-associated immunoglobulin A receptor FcαRI (transient engagement of small numbers of FcαRIs) results in translocation of FcαRI and the associated inhibitory Src homology 2 (SH2) domain-containing phosphatase-1 (SHP-1) to membrane lipid rafts. Subsequent ligation of activating receptors results in their colocalization with FcαRI and SHP-1 and trafficking to an inhibitory intracellular compartment termed the inhibisome. Thus, ITAM suppressive signals subvert the activating function of rafts to promote incorporation of receptors into supramolecular domains where signaling molecules are deactivated by SHP-1.
Figures

Similar articles
-
Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters.Sci Signal. 2011 Apr 19;4(169):ra24. doi: 10.1126/scisignal.2001309. Sci Signal. 2011. PMID: 21505186
-
Inhibitory ITAMs as novel regulators of immunity.Immunol Rev. 2009 Nov;232(1):59-71. doi: 10.1111/j.1600-065X.2009.00832.x. Immunol Rev. 2009. PMID: 19909356 Review.
-
IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth.Blood. 2007 Jan 1;109(1):203-11. doi: 10.1182/blood-2006-06-025882. Epub 2006 Sep 21. Blood. 2007. PMID: 16990604
-
Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway.Arthritis Rheumatol. 2015 Jul;67(7):1766-77. doi: 10.1002/art.39142. Arthritis Rheumatol. 2015. PMID: 25833812
-
Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.Immunol Rev. 2015 Nov;268(1):66-73. doi: 10.1111/imr.12336. Immunol Rev. 2015. PMID: 26497513 Free PMC article. Review.
Cited by
-
A Lupus-Associated Mac-1 Variant Has Defects in Integrin Allostery and Interaction with Ligands under Force.Cell Rep. 2015 Mar 17;10(10):1655-1664. doi: 10.1016/j.celrep.2015.02.037. Epub 2015 Mar 12. Cell Rep. 2015. PMID: 25772353 Free PMC article.
-
Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Expert Opin Biol Ther. 2016;16(5):655-74. doi: 10.1517/14712598.2016.1152256. Epub 2016 Feb 25. Expert Opin Biol Ther. 2016. PMID: 26855028 Free PMC article. Review.
-
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications.Mol Ther Oncolytics. 2021 Aug 19;22:166-179. doi: 10.1016/j.omto.2021.08.005. eCollection 2021 Sep 24. Mol Ther Oncolytics. 2021. PMID: 34514097 Free PMC article. Review.
-
IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcγRI.MAbs. 2014;6(6):1377-84. doi: 10.4161/19420862.2014.975657. MAbs. 2014. PMID: 25484046 Free PMC article.
-
Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.Front Immunol. 2017 Apr 7;8:394. doi: 10.3389/fimmu.2017.00394. eCollection 2017. Front Immunol. 2017. PMID: 28439271 Free PMC article. Review.
References
-
- Ravetch JV, Lanier LL. Immune inhibitory receptors. Science. 2000;290:84–89. - PubMed
-
- Pfirsch-Maisonnas S, Aloulou M, Xu T, Claver J, Kanamaru Y, Tiwari M, Launay P, Monteiro RC, Blank U. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized “inhibisome” clusters. Sci Signal. 2011;4:ra24. - PubMed
-
- Abram CL, Lowell CA. The expanding role for ITAM-based signaling pathways in immune cells. Sci STKE. 2007;2007:re2. - PubMed
-
- Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous